Wu, S.; Nitschke, K.; Heinkele, J.; Weis, C.-A.; Worst, T.S.; Eckstein, M.; Porubsky, S.; Erben, P.
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data. Cancers 2019, 11, 1840.
https://doi.org/10.3390/cancers11121840
AMA Style
Wu S, Nitschke K, Heinkele J, Weis C-A, Worst TS, Eckstein M, Porubsky S, Erben P.
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data. Cancers. 2019; 11(12):1840.
https://doi.org/10.3390/cancers11121840
Chicago/Turabian Style
Wu, Sheng, Katja Nitschke, Jakob Heinkele, Cleo-Aron Weis, Thomas Stefan Worst, Markus Eckstein, Stefan Porubsky, and Philipp Erben.
2019. "ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data" Cancers 11, no. 12: 1840.
https://doi.org/10.3390/cancers11121840
APA Style
Wu, S., Nitschke, K., Heinkele, J., Weis, C. -A., Worst, T. S., Eckstein, M., Porubsky, S., & Erben, P.
(2019). ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data. Cancers, 11(12), 1840.
https://doi.org/10.3390/cancers11121840